View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Bankwell Financial Group: 1 director

A director at Bankwell Financial Group bought 10,036 shares at 46.939USD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

 PRESS RELEASE

Bread Financial Provides Performance Update for February 2026

Bread Financial Provides Performance Update for February 2026 COLUMBUS, Ohio, March 11, 2026 (GLOBE NEWSWIRE) --  (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions to millions of U.S. consumers, provided a performance update. The following tables present the Company’s Net principal loss rate and Delinquency rate for the periods indicated:  For themonth endedFebruary 28, 2026 For themonth endedFebruary 28, 2025 (dollars in millions)End-of-period credit card and other loans$18,081  $17,949 Average credit card and...

 PRESS RELEASE

Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Marke...

Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum CHASKA, Minn., March 10, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming KeyBanc Capital Markets Healthcare Virtual Forum. Details regarding Lifecore’s participation are as follows: 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum Details: Mr. Josephs will be a featured speaker in a fireside chat...

 PRESS RELEASE

Ford and Bread Financial Accelerate Customer Benefits with New Financi...

Ford and Bread Financial Accelerate Customer Benefits with New Financing Program— Unlocking Enhanced Experiences and Exclusive Loyalty Rewards New long-term agreement includes co-brand credit card and installment loan programs, delivering tailored solutions to qualifying customersCardholders can enjoy access to instant purchasing power, flexible payment plans and unique Ford benefits DEARBORN, Mich. and COLUMBUS, Ohio, March 10, 2026 (GLOBE NEWSWIRE) -- Ford Motor Company (NYSE: F) today announced a new long-term agreement with Bread Financial (NYSE: BFH), a tech-forward financial servic...

 PRESS RELEASE

Lifecore Biomedical to Report Financial Results for the Fourth Quarter...

Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026 Webcast Scheduled for Monday, March 16 at 8:30 a.m. Eastern CHASKA, Minn., March 09, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the fourth quarter and transition period ended December 31, 2025, on Monday, March 16, 2026, before the market opens. At 8:30 a.m. Eastern Time t...

David Nierengarten ... (+3)
  • David Nierengarten
  • Dennis Pak
  • Martin Fan
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 7, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Northern Oil and Gas, Inc. (NOG) and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 27 February 2026 in which we reassessed the appropriateness of the ratings...

 PRESS RELEASE

Lifecore Biomedical Signs New Agreement with Indomo to Support Innovat...

Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment Indomo Developing Fast-Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen™, its Proprietary Intradermal Self-Injection Device Lifecore to Manufacture Drug Batches in Preparation for Planned Clinical Trials CHASKA, Minn. and BOSTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), and Indomo, a clini...

 PRESS RELEASE

Bread Financial to Participate in the RBC 2026 Financial Institutions ...

Bread Financial to Participate in the RBC 2026 Financial Institutions Conference COLUMBUS, Ohio, March 04, 2026 (GLOBE NEWSWIRE) -- (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions, today announced the company’s participation in the RBC 2026 Financial Institutions Conference on Wednesday, March 11. Bread Financial EVP and Chief Financial Officer Perry Beberman will participate in a fireside chat. The fireside chat will take place at 2:00 p.m. ET and will be broadcast live The fireside chat can also be acce...

 PRESS RELEASE

Insight Molecular Diagnostics Completes Key Milestones Advancing Graft...

Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission Three-site reproducibility study completed by Tampa General Hospital, Mayo Clinic, and Baylor Scott & White HealthSufficient clinical samples collected to support statistical analysis and FDA submissionCompany achieved final ISO 13485 certification on Feb. 26, enabling U.K. and E.U. regulatory submissions NASHVILLE, Tenn., March 03, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) (“iMDx”) today announced that in February the company completed several major miles...

 PRESS RELEASE

Aclaris Therapeutics to Participate in the Leerink Partners 2026 Globa...

Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference WAYNE, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on Tuesday March 10, 2026, at 1:40 PM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Leerink Partners 2026 Global Healthcare Conference in Miami, FL. A live a...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 28, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Coty Inc. - December 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Macy's, Inc.: Update to credit analysis

Our credit view of Macy's reflects its very good liquidity and its integrated approach to stores and online, against its low retail operating margins.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch